Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms 3CLproPROTACs (Shaanxi Panlong Pharmaceutical/Shaanxi University of Science & Technology), PLC 01, PLC01 |
Target |
Action degraders |
Mechanism SARS-CoV-2 3CLpro degraders(SARS-CoV-2-3C-like-proteinase degraders) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| COVID-19 | Preclinical | China | 13 Apr 2022 | |
| COVID-19 | Preclinical | China | 13 Apr 2022 |





